Correction to: Curr Atheroscler Rep (2011) 13:31–42
A portion of this article was previously published as part of an article titled “Human C-reactive protein and the metabolic syndrome” in the following journal: Curr Opin Lipidol. 2009 Jun;20(3):182–9. https://doi.org/10.1097/MOL.0b013e32832ac03e. https://insights.ovid.com/crossref?an=00041433-200906000-00007.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s11883-010-0143-2
Rights and permissions
About this article
Cite this article
Devaraj, S., Siegel, D. & Jialal, I. Correction to: Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?. Curr Atheroscler Rep 21, 3 (2019). https://doi.org/10.1007/s11883-019-0768-8
Published:
DOI: https://doi.org/10.1007/s11883-019-0768-8